Ekso bionics reports record annual revenue of $18.3 million

Sold record number of annual eksohealth units in 2023 san rafael, calif., march 04, 2024 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended december 31, 2023.
EKSO Ratings Summary
EKSO Quant Ranking